William T Lowther

9PUBLICATIONS
28CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsFree radical chemistryMolecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 31, 2025
Mechanism-based peroxiredoxin 3 inhibitors exploit a covalent warhead for cancer therapy.

Kimberly J Nelson, Terrence L Smalley, Terri Messier

|Apr 07, 2025
Characterization of CHK-336, A First-in-Class, Liver-Targeted, Small-Molecule Lactate Dehydrogenase Inhibitor for Hyperoxaluria Treatment.

Jennifer H Cox, Marc-Olivier Boily, Alexandre Caron

|Jul 02, 2021
Specificity of Human Sulfiredoxin for Reductant and Peroxiredoxin Oligomeric State.

Tom E Forshaw, Julie A Reisz, Kimberly J Nelson

|Jan 27, 2021
Unique Cellular and Biochemical Features of Human Mitochondrial Peroxiredoxin 3 Establish the Molecular Basis for Its Specific Reaction with Thiostrepton.

Kimberly J Nelson, Terri Messier, Stephanie Milczarek

|Dec 08, 2020
Discovery of Spilanthol Endoperoxide as a Redox Natural Compound Active against Mammalian Prx3 and Chlamydia trachomatis Infection.

Rosine Dushime, Yunhuang Zhu, Hanzhi Wu

|Dec 02, 2020
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease.

Emily E Oliver, Erin K Hughes, Meaghan K Puckett

Pageof 2

Frequent Collaborators

2 joint publications

Tom E Forshaw

2 joint publications

Stephanie Milczarek

1 joint publications

Jing Yang

1 joint publications

Kate S Carroll